MedPath

CRYONOVE PHARMA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

13

Active:0
Completed:10

Trial Phases

1 Phases

Not Applicable:13

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Not Applicable
13 (100.0%)

Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face

Not Applicable
Completed
Conditions
Lentigo
Solar Lentigo
Post Inflammatory Hyperpigmentation
First Posted Date
2024-04-11
Last Posted Date
2024-12-24
Lead Sponsor
Cryonove Pharma
Target Recruit Count
30
Registration Number
NCT06361251
Locations
🇿🇦

SMU - Photobiology Laboratory, Sefako Makgatho Health Sciences University, Pretoria, South Africa

Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face

Not Applicable
Not yet recruiting
Conditions
Solar Lentigo
Lentigo
Post Inflammatory Hyperpigmentation
First Posted Date
2024-03-12
Last Posted Date
2024-04-17
Lead Sponsor
Cryonove Pharma
Target Recruit Count
45
Registration Number
NCT06305897

Performance and Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in th Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) on the Face and Hands of Asian Ethnicity Skins

Not Applicable
Not yet recruiting
Conditions
Solar Lentigo
Senile Lentigo
First Posted Date
2023-06-02
Last Posted Date
2023-06-02
Lead Sponsor
Cryonove Pharma
Target Recruit Count
120
Registration Number
NCT05886010
Locations
🇫🇷

Laboratoire BIO-EC, Longjumeau, France

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation)

Not Applicable
Not yet recruiting
Conditions
Solar Lentigo
Post Inflammatory Hyperpigmentation
Senile Lentigo
First Posted Date
2023-06-01
Last Posted Date
2023-06-01
Lead Sponsor
Cryonove Pharma
Target Recruit Count
80
Registration Number
NCT05883657
Locations
🇿🇦

Photobiology Laboratory, Sefako Makgatho Health Sciences University, Pretoria, Gauteng, South Africa

Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Not Applicable
Completed
Conditions
Lentigo Solar
Senile Lentigo
First Posted Date
2023-03-31
Last Posted Date
2023-11-03
Lead Sponsor
Cryonove Pharma
Target Recruit Count
20
Registration Number
NCT05793619
Locations
🇬🇪

Ltd "Health", Batumi, Georgia

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.